Thrivent Financial for Lutherans lowered its position in Plexus Corp. (NASDAQ:PLXS – Free Report) by 9.7% in the second quarter, HoldingsChannel.com reports. The fund owned 278,869 shares of the technology company’s stock after selling 29,851 shares during the quarter. Thrivent Financial for Lutherans’ holdings in Plexus were worth $37,734,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
A number of other hedge funds and other institutional investors also recently modified their holdings of the company. Huntington National Bank increased its stake in shares of Plexus by 41.5% during the 2nd quarter. Huntington National Bank now owns 324 shares of the technology company’s stock worth $44,000 after purchasing an additional 95 shares during the last quarter. Banque Transatlantique SA bought a new position in Plexus during the first quarter worth about $71,000. CWM LLC grew its holdings in Plexus by 65.7% during the second quarter. CWM LLC now owns 537 shares of the technology company’s stock worth $73,000 after purchasing an additional 213 shares during the period. EverSource Wealth Advisors LLC increased its position in Plexus by 583.3% during the second quarter. EverSource Wealth Advisors LLC now owns 574 shares of the technology company’s stock worth $78,000 after buying an additional 490 shares during the last quarter. Finally, TD Private Client Wealth LLC raised its stake in Plexus by 31.5% in the second quarter. TD Private Client Wealth LLC now owns 676 shares of the technology company’s stock valued at $91,000 after buying an additional 162 shares during the period. Institutional investors own 94.45% of the company’s stock.
Analyst Ratings Changes
Several research analysts have recently commented on PLXS shares. Benchmark reiterated a “buy” rating and set a $165.00 target price on shares of Plexus in a research note on Friday, October 24th. Wall Street Zen downgraded Plexus from a “buy” rating to a “hold” rating in a report on Saturday, November 22nd. Williams Trading set a $165.00 price objective on shares of Plexus in a report on Monday, September 22nd. Stifel Nicolaus set a $150.00 price objective on shares of Plexus in a research report on Friday, October 24th. Finally, Weiss Ratings restated a “hold (c+)” rating on shares of Plexus in a research note on Wednesday, October 8th. Two research analysts have rated the stock with a Buy rating and three have given a Hold rating to the stock. According to MarketBeat, the company has a consensus rating of “Hold” and a consensus price target of $159.00.
Plexus Stock Performance
PLXS opened at $159.72 on Tuesday. The company has a debt-to-equity ratio of 0.06, a current ratio of 1.58 and a quick ratio of 0.77. The business has a fifty day simple moving average of $145.40 and a 200 day simple moving average of $138.76. Plexus Corp. has a 1 year low of $103.43 and a 1 year high of $172.89. The company has a market capitalization of $4.28 billion, a PE ratio of 25.51 and a beta of 0.81.
Plexus (NASDAQ:PLXS – Get Free Report) last posted its quarterly earnings data on Wednesday, October 22nd. The technology company reported $2.14 earnings per share for the quarter, topping the consensus estimate of $1.84 by $0.30. Plexus had a return on equity of 12.77% and a net margin of 4.29%.The firm had revenue of $1.06 billion for the quarter, compared to analysts’ expectations of $1.05 billion. During the same quarter last year, the business earned $1.85 EPS. The company’s quarterly revenue was up .7% compared to the same quarter last year. Plexus has set its Q1 2026 guidance at 1.660-1.810 EPS. Research analysts expect that Plexus Corp. will post 5.9 EPS for the current year.
Insider Activity
In related news, CAO Angelo Michael Ninivaggi, Jr. sold 1,347 shares of the firm’s stock in a transaction on Wednesday, November 26th. The stock was sold at an average price of $144.93, for a total value of $195,220.71. Following the transaction, the chief accounting officer owned 21,544 shares in the company, valued at approximately $3,122,371.92. This trade represents a 5.88% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, CEO Todd P. Kelsey sold 2,000 shares of the business’s stock in a transaction dated Tuesday, November 4th. The shares were sold at an average price of $143.50, for a total value of $287,000.00. Following the completion of the transaction, the chief executive officer directly owned 60,714 shares of the company’s stock, valued at approximately $8,712,459. This trade represents a 3.19% decrease in their position. The SEC filing for this sale provides additional information. Over the last 90 days, insiders have sold 13,172 shares of company stock worth $1,883,740. 1.76% of the stock is currently owned by insiders.
Plexus Profile
Plexus Corp. provides electronic manufacturing services in the United States and internationally. It offers design, develop, supply chain, new product introduction, and manufacturing solutions, as well as sustaining services to companies in the healthcare/life sciences, industrial/commercial, aerospace/defense, and communications market sectors.
See Also
- Five stocks we like better than Plexus
- How to start investing in penny stocks
- Unassuming Evergy Energy: The AI Boost Your Income Portfolio Needs
- How the NYSE and NASDAQ are Different, Why That Matters to Investors
- Pfizer Adds to Its Big Bet on Weight Loss Drugs
- What is the Australian Securities Exchange (ASX)
- ServiceNow’s $7 Billion Gamble: Panic or Opportunity?
Want to see what other hedge funds are holding PLXS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Plexus Corp. (NASDAQ:PLXS – Free Report).
Receive News & Ratings for Plexus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Plexus and related companies with MarketBeat.com's FREE daily email newsletter.
